Lataa...
Preclinical Assessment of Cardiac Valve Substitutes: Current Status and Considerations for Engineered Tissue Heart Valves
Tissue engineered heart valve (TEHV) technology may overcome deficiencies of existing available heart valve substitutes. The pathway by which TEHVs will undergo development and regulatory approval has several challenges. In this communication, we review: (1) the regulatory framework for regulation o...
Tallennettuna:
| Julkaisussa: | Front Cardiovasc Med |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6566127/ https://ncbi.nlm.nih.gov/pubmed/31231661 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2019.00072 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|